We are excited to announce that we will be presenting at the 3rd Antigen-Specific Immune Tolerance Drug Development conference.  We will be discussing AnTolRx’s antigen-specific nanoformulation platform for the treatment of autoimmune diseases! Come join us in Boston on February 25-27, 2020.

Click here to learn more about ASIT